Adam Drapczuk
Förmögenhet: 61 315 $ per 2026-06-30
Förmögenhet: 61 315 $ per 2026-06-30
Adam E.
Drapczuk worked at West-Ward Pharmaceutical Corp.
from 2001 to 2011, serving as Finance Director from 2008 to 2011.
From 2011 to 2016, worked at Tris Pharma, Inc. as Finance Director & Controller.
In 2016, held the position of Chief Financial Officer & Vice President-Finance at Inpellis, Inc. Also in 2016, worked as Financial Controller at R-Pharm US LLC until 2020.
From 2021 to 2025, served as Chief Financial & Accounting Officer at NexGel, Inc., continuing in that role through 2026.
Education includes undergraduate studies at Susquehanna University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NEXGEL, INC. 1,33 % | 2026-06-03 | 122 385 ( 1,33 % ) | 61 315 $ | 2026-06-30 |
| Företag | Position | Slut |
|---|---|---|
| NEXGEL, INC. | Comptroller/Controller/Revisor | 2026-04-27 |
| NEXGEL, INC. | Finansdirektör/CFO | 2025-12-31 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Comptroller/Controller/Revisor | 2020-04-01 |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Finansdirektör/CFO | 2016-04-01 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Finansdirektör/CFO | 2016-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Susquehanna University
Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Provides generic prescription medication services | Health Technology |
NexGel, Inc.
NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån